Loading data
DEONYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 27.76 bn USD | 27.96 bn USD | 27.89 bn USD | 28.27 bn USD | 29.75 bn USD |
| Cost of revenue | 7.96 bn USD | 8.07 bn USD | 8.07 bn USD | 8.29 bn USD | 7.92 bn USD |
| Gross profit | 11.68 bn USD | 12.17 bn USD | 12.2 bn USD | 12.27 bn USD | 12.59 bn USD |
| Research and development expense | 71 m USD | 74 m USD | 69 m USD | 63 m USD | 58 m USD |
| Operating profit | 3.16 bn USD | 4.34 bn USD | 6 bn USD | 5.55 bn USD | 5.9 bn USD |
| Interest expense | 1.09 bn USD | 1.15 bn USD | 1.19 bn USD | 1.03 bn USD | 1.09 bn USD |
| Profit before tax | 2.56 bn USD | 3.54 bn USD | 5.46 bn USD | 5.64 bn USD | 5.81 bn USD |
| Income tax expense | 606 m USD | 999 m USD | 1.29 bn USD | 1.16 bn USD | 1.4 bn USD |
| Net income (reported basis) | 1.96 bn USD | 2.54 bn USD | 4.17 bn USD | 4.48 bn USD | 4.41 bn USD |
| Basic earnings per share | 0.78 USD/share | 1.06 USD/share | 1.73 USD/share | 1.96 USD/share | 1.85 USD/share |
| Diluted earnings per share | 0.78 USD/share | 1.06 USD/share | 1.73 USD/share | 1.96 USD/share | 1.84 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.